Investors & Media

analyst coverage

Firm Analyst
Barclays
Gena Wang
Bank of America Merrill Lynch
Ying Huang
Bernstein
Vincent Chen
BMO Capital Markets
Matthew Luchini
BTIG
Dane Leone
Canaccord Genuity
John Newman
Cantor Fitzgerald
Elemer Piros Ph.D.
Cowen
Chris Shibutani
Evercore ISI
Joshua Schimmer M.D.
Goldman Sachs
Salveen Richter
Janney
Yun Zhong Ph.D.
J.P. Morgan
Cory Kasimov
Jefferies
Biren Amin
Maxim Group
Jason McCarthy Ph.D.
Morgan Stanley
Matthew Harrison
Oppenheimer
Mark Breidenbach
Piper Jaffray & Co
Tyler Van Buren
SunTrust Robinson Humphrey
Edward Nash
Wedbush PacGrowth Life Sciences
David Nierengarten Ph.D.
Wells Fargo
Jim Birchenough
William Blair
Raju Prasad Ph.D.

bluebird bio, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding bluebird bio, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of bluebird bio, Inc. or its management. bluebird bio, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Media Contact

Stephanie Fagan

Senior Vice President, Corporate Communications

(201) 572-9581

sfagan@bluebirdbio.com

 

Investor Contact

Elizabeth Pingpank

Associate Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com